Angle Biosciences Inc:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Angle Biosciences Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C6437
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Angle Biosciences Inc (Angle Biosciences), formerly Axela Inc, is a provider of optic technology solutions. The company offers Ziplex system, Flow-thru TipChips, panelPlus TipChips, diffractive optics technology, diffractive optics sensors, panelPlus sensors and software products. It offers technical and applications support, on-site and in-house training, extended warranty, service and maintenance contracts; and custom application development services. Angle Biosciences offers software for method creation, data gathering and data analysis. The company’s products are used in simplify multiplex biomarker detection for translational research and diagnostic testing. It markets its products in Canada, Ireland, Belgium, Luxemburg, Spain, the Netherlands, the UK and the US. Angle Biosciences is headquartered in Toronto, Ontario, Canada.

Angle Biosciences Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Angle Biosciences Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Angle Biosciences Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Angle Biosciences Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Angle Biosciences Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Angle Biosciences Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Angle Biosciences Inc, Medical Equipment, Deal Details 10
Partnerships 10
Scienion Enters into Co-Development Agreement with Axela 10
PAML Enters into Co-Development Agreement with Axela 11
Axela Enters Technology Integration Agreement With Hutman Diagnostics 12
Axela Enters Into Technology Integration Agreement With Thermal Gradient 13
Axela Enters Into Co-Marketing Agreement With OvaGene Oncology 14
Isogen Life Science Enters Into Co-Marketing Agreement With Axela For Biomarker Analysis Platforms 15
Asset Transactions 16
ANGLE Acquires Assets from Axela 16
Acquisition 17
Axela Mulls Offering Itself For Sale 17
Angle Biosciences Inc – Key Competitors 18
Angle Biosciences Inc – Key Employees 19
Angle Biosciences Inc – Locations And Subsidiaries 20
Head Office 20
Recent Developments 21
Other Significant Developments 21
Apr 10, 2017: Rapid blood test for intracranial hemorrhage in well appearing infants: a comprehensive brain injury study using Axela’s Flow-Thru Chip platform 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
Angle Biosciences Inc, Medical Equipment, Key Facts 2
Angle Biosciences Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Angle Biosciences Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Angle Biosciences Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Angle Biosciences Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Angle Biosciences Inc, Deals By Market, 2012 to YTD 2018 8
Angle Biosciences Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Scienion Enters into Co-Development Agreement with Axela 10
PAML Enters into Co-Development Agreement with Axela 11
Axela Enters Technology Integration Agreement With Hutman Diagnostics 12
Axela Enters Into Technology Integration Agreement With Thermal Gradient 13
Axela Enters Into Co-Marketing Agreement With OvaGene Oncology 14
Isogen Life Science Enters Into Co-Marketing Agreement With Axela For Biomarker Analysis Platforms 15
ANGLE Acquires Assets from Axela 16
Axela Mulls Offering Itself For Sale 17
Angle Biosciences Inc, Key Competitors 18
Angle Biosciences Inc, Key Employees 19

List of Figures
Angle Biosciences Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Angle Biosciences Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Angle Biosciences Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Angle Biosciences Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Angle Biosciences Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Angle Biosciences Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Angle Biosciences Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Angle Biosciences Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Angle Biosciences Inc:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Bechtel Corporation:企業の戦略的SWOT分析
    Bechtel Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Arlington Asset Investment Corp (AI):企業の財務・戦略的SWOT分析
    Summary Arlington Asset Investment Corp (AAIC) is an investment firm that offers asset management and investment services. The firm acquires and holds mortgage-related assets. It acquires residential mortgage-backed securities issued by the US government agencies. AAIC also acquires mortgage-backed …
  • Precision Optics Corporation Inc (PEYE):企業の財務・戦略的SWOT分析
    Summary Precision Optics Corporation Inc (Precision Optics) is a medical device company that designs, develops, manufactures and distributes optics and optical systems for medical, biomedical, and industrial applications. The company provides custom optics solutions such as design and prototyping, f …
  • University of Pittsburgh Medical Center:企業の戦略的SWOT分析
    University of Pittsburgh Medical Center - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and m …
  • Kuwait And Middle East Financial Investment Company (K.S.C.P.) (KMEFIC):企業の財務・戦略的SWOT分析
    Kuwait And Middle East Financial Investment Company (K.S.C.P.) (KMEFIC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view …
  • ResApp Health Ltd (RAP):製薬・医療:M&Aディール及び事業提携情報
    Summary ResApp Health Ltd (ResApp) formerly, Narhex Life Sciences Limited is a digital health company that develops smartphone applications for the diagnosis and management of respiratory disease. It's digital healthcare solutions assist doctors and patients to diagnose and manage respiratory diseas …
  • Capitol Health Ltd (CAJ)-医療機器分野:企業M&A・提携分析
    Summary Capitol Health Ltd (Capitol Health) is a medical device company that provides diagnostic imaging and related services. The company provides services such as bone densitomety, computer tomography, cone beam CT, CT angiography, doppler, echocardiography, fluoroscopy, general X-ray, magnetic re …
  • Symrise AG (SY1):企業の財務・戦略的SWOT分析
    Symrise AG (SY1) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Wexford Health Sources Inc:企業の戦略的SWOT分析
    Wexford Health Sources Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Eisai Co Ltd (4523):企業の財務・戦略的SWOT分析
    Eisai Co Ltd (4523) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Syndax Pharmaceuticals Inc (SNDX):製薬・医療:M&Aディール及び事業提携情報
    Summary Syndax Pharmaceuticals Inc (Syndax) is a biopharmaceutical company that develops and commercializes therapies for multiple cancer indications. The company’s lead product candidate includes entinostat, an oral, small molecule drug candidate, which is in phase 3 clinical trial used for the tre …
  • Jacobs Engineering Group Inc.:企業の戦略・SWOT・財務情報
    Jacobs Engineering Group Inc. - Strategy, SWOT and Corporate Finance Report Summary Jacobs Engineering Group Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • PT Kimia Farma (KAEF):企業の財務・戦略的SWOT分析
    PT Kimia Farma (KAEF) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Camel-IDS NV:製薬・医療:M&Aディール及び事業提携情報
    Summary Camel-IDS NV (Camel-IDS) is a biotechnology company that develops radio-immunotherapeutic drugs for cancer patients. The company offers developing of compound radiopharmaceutical drugs for treatment of Her2 positive cancer. Its technology platform is based on recombinant, small antigen-bindi …
  • Scilex Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Scilex Pharmaceuticals Inc (Scilex Pharma), a subsidiary of Sorrento Therapeutics Inc is a developer of pharmaceutical products. The company develops and commercializes branded pharmaceutical products for the treatment of pain. Its technologies include drug delivery and proprietary patch tec …
  • Johnson Electric Holdings Limited:企業の戦略・SWOT・財務情報
    Johnson Electric Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Johnson Electric Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Inditex SA (ITX):企業の財務・戦略的SWOT分析
    Inditex SA (ITX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Mitsui & Co Ltd (8031):石油・ガス:M&Aディール及び事業提携情報
    Summary Mitsui & Co Ltd (Mitsui) is a business conglomerate. The company sells, distributes, purchases, markets and supplies wide variety of products in business areas including iron and steel; non-ferrous metals; machinery; electronics; chemicals; energy-related commodities; foods & retail, lifesty …
  • Bone Biologics Corp (BBLG):企業の製品パイプライン分析
    Summary Bone Biologics Corp (Bone Biologics) is a biotechnology company that develops orthobiologic products. It develops NELL-1, a recombinant human protein growth factor, which is essential for normal bone development. It offers bone graft substitutes for spine fusion. Bone Biologics also offers N …
  • Logitech International SA (LOGN):企業の財務・戦略的SWOT分析
    Logitech International SA (LOGN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆